This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Citi Reaffirms Their Hold Rating on Cemex SAB (CX)

Tipranks - Tipranks - Sat Jul 4, 11:34AM CDT

In a report released yesterday, Andres Cardona from Citi maintained a Hold rating on Cemex SAB, with a price target of $13.00. The company’s shares closed yesterday at $12.29.

4th of July Sale - 70% Off

According to TipRanks, Cardona is ranked #2993 out of 12296 analysts.

Cemex SAB has an analyst consensus of Moderate Buy, with a price target consensus of $14.01, which is a 14.00% upside from current levels. In a report released yesterday, RBC Capital also maintained a Hold rating on the stock with a $12.75 price target.

See today’s best-performing stocks on TipRanks >>

Based on Cemex SAB’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $4.02 billion and a net profit of $227.66 million. In comparison, last year the company earned a revenue of $3.61 billion and had a net profit of $733.96 million

Based on the recent corporate insider activity of 43 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CX in relation to earlier this year. Most recently, in April 2026, Jesus Vicente Gonzalez Herrera, the President of Cemex USA of CX sold 35,000.00 shares for a total of $425,600.00.

Read More on CX:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).